Inflammatory Breast Cancer - RAD174

Inflammatory Breast Cancer

Rare and Aggressive

by Steven S. Bhimji, MD, PhD
(4.5 / 0 ratings )

This course is credentialed for:
Radiologic Technology (1.00 CE Credit)

Price: $10.00
CE-PRO Price: $5.00


Inflammatory breast cancer is not a common type of breast cancer. Overall, it accounts for about 2% to 5% of all cases of breast cancer. Inflammatory breast cancer develops and progresses rapidly, which accounts for a poor prognosis. The median survival for patients with inflammatory breast cancer is 15 months, even with treatment. It presents with signs and symptoms of inflammation, and is often mistaken for cellulitis. Physical exam may reveal a warm, indurated and erythematous breast, without an underlying mass, but axillary adenopathy is common. Also, it may present as a reddened breast, without systemic features of inflammation. Prompt biopsy followed by treatment by an interprofessional team is highly recommended. Unlike other breast cancers, initial treatment of inflammatory breast cancer is chemotherapy, followed by surgery and radiation.


The goal of this inflammatory breast cancer continuing education program is to provide pharmacists, physicians and imaging technologists with information about inflammatory breast cancer, its pathophysiology, presentation and treatment. After studying the information presented here, you will be able to:
  • Describe the pathology, presentation and examination of patients with inflammatory breast cancer
  • Discuss the role of chemotherapy, surgery and radiation in patients with primary inflammatory breast cancer, including management of adverse effects
  • List the novel types of treatment for patients with advanced inflammatory breast cancer
  • Discuss the types of cancer drugs used to treat inflammatory breast cancer
  • List other non-drug therapies for treatment of inflammatory breast cancer

Approval Information
This course is intended for an interprofessional audience, including pharmacists, physicians and imaging technologists.
Pharmacists: Take this version of the course to ensure you receive appropriate credit.
For the version accredited or approved for another profession, go to your specific profession at or If you have a CE Direct login ID and password (generally provided by your employer), please log in as you normally would at and search for this topic title.
This activity is approved for Category A continuing education credit by the American Society of Radiologic Technologists (ASRT) for 09/02/2015 to 10/01/2018.
This activity may be available in multiple formats or from different sponsors. ARRT regulations state that an individual may not repeat a self-learning activity for credit if it was reported in the same or any subsequent biennium.

Course Originally Released on: 11/13/2014
Date of Most Recent Review: 11/13/2014
Course Termination/Update Date: 10/1/2018

Unless stated above, the planners and authors of this course have declared no relevant conflicts of interest that relate to this educational activity. OnCourse Learning guarantees this educational activity is free from bias.

Please see CE Course Instructions to learn how to earn CE credit for this module.

Sort By
KAREN R - WILLISTON, FL  ·  Oct 16, 2017
This was new information to me about this type of breast cancer. This inflammatory type presents with a different set of symptoms than other breast cancers.
Was this review helpful?  0
Corey B - Sanford, FL  ·  Oct 14, 2017
very informative course
Was this review helpful?  0
Cristina B - Scottsdale, AZ  ·  Oct 09, 2017
great read, very informative & well worded
Was this review helpful?  0
Nicole A - Atco, NJ  ·  Oct 08, 2017
This course was very informative.
Was this review helpful?  0
TERRI K - Manistee, MI  ·  Sep 29, 2017
Good course touched base on inflammatory breast cancer and the RAD role with it.
Was this review helpful?  0
  Page: of 30  
Price: $10.00
CE-PRO Price: $5.00